MET and neoplasm: Herein, we reported, for the first time, that ESM1 activates the downstream MAPK pathway by binding to the membrane receptor c-Met on the surface of HUVEC cells to promote the production of HIF1α, VEGFA, and MMP9, eventually promoting tumor angiogenesis.